Supplementary Table 1. Identification of 209 (FC > 2.0) enes that were overexpressed in lymph nodes

Table 1. Transcriptional profiling reveals differential expression of genes associated with apoptosis in SP-C?exon4 cells

Table S1. Descriptive information about apoptosis-associated genes from PathwayAssist model

Supplemental table 2    EAC-specific genes  ( EAC vs.  NE)

Table 1. Functional categories of significantly differentially expressed genes in EAC and BEa relative to NE

Supplemental table 1 Barrett's-specific genes (BE vs. NE)

Table 1. Gene expression changes associated with anoikis  anchorage independence  migration  or nonanchored growth

Table 2. KLF2-responsive genes assigned to the principal categories of endothelial function

Table 1. Effect of KLF2 on the expression of endothelial lineage markers

Table TS1-Transcript profiling of HER-2 overexpressing MCF-7 breast cancer cells reveals TGF-á pathway alterations...

Table 2 The 22 genes up-regulated 3-fold or greater in AML-2/DX100 cells compared to AML-2/WT cells

Table 3 The 27 genes down-regulated 3-fold or greater in AML-2/DX100 cells compared to AML-2/WT cells

Table I. Gene expression profile after inhibiting Raf-1 expression using antisense raf oligonucleotide in MDA-MB-231 cells.

Table 2B. Mucinous LMP vs cystadenoma. Differentially expressed genes (P < 0.001) unique to mucinous tumors versus serous specimens that are secreted or membrane bound (A)  genes up-regulated in mucinous LMP tumors versus OSE and cystadenomas (B)  and genes up-regulated in mucinous adenocarcinomas versus OSE and cystadenomas (C)

Table 2C. Mucinous adenocarcinoma vs cystadenoma. Differentially expressed genes (P < 0.001) unique to mucinous tumors versus serous specimens that are secreted or membrane bound (A)  genes up-regulated in mucinous LMP tumors versus OSE and cystadenomas (B)  and genes up-regulated in mucinous adenocarcinomas versus OSE and cystadenomas (C)

Table 2A. Mucinous tumor markers. Differentially expressed genes (P < 0.001) unique to mucinous tumors versus serous specimens that are secreted or membrane bound (A)  genes up-regulated in mucinous LMP tumors versus OSE and cystadenomas (B)  and genes up-regulated in mucinous adenocarcinomas versus OSE and cystadenomas (C).